RELMADA THERAPEUTICS, INC. Payments for (Proceeds from) Investments
RELMADA THERAPEUTICS, INC. (RLMD) reported Payments for (Proceeds from) Investments of $447.72 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-05.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsForProceedsFromInvestments · last filed 2022-05-05
- RELMADA THERAPEUTICS, INC. payments for (proceeds from) investments for the quarter ending 2022-03-31 was $447.72K.
- RELMADA THERAPEUTICS, INC. payments for (proceeds from) investments for the quarter ending 2020-06-30 was $75.96M.
- RELMADA THERAPEUTICS, INC. payments for (proceeds from) investments for the quarter ending 2020-03-31 was -$13.60M.
| Period end | Payments for (Proceeds from) Investments 3 month | Payments for (Proceeds from) Investments 6 month |
|---|---|---|
| 2022-03-31 | $447.72K 10-Q · filed 2022-05-05 | |
| 2020-06-30 | $75.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $62.36M 10-Q · filed 2020-08-12 |
| 2020-03-31 | -$13.60M 10-Q · filed 2020-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |